Search

Search Constraints

You searched for: Author/Creator Lanoy, E.

Search Results

4. 349 Impact of the re-definition of dose-limiting toxicities (DLTs) according to recent recommendations on the DLT rate in phase 1 trials of molecularly targeted agents. (September 2015)

5. PO-1227: A dose escalation phase 1 study of radiotherapy combined with ipilimumab in metastatic melanoma. (November 2020)